Review article · 2024

Nitrogen-containing heterocyclic drug products approved by the FDA in 2023: Synthesis and biological activity

Weijiang Luo, Yiqi Liu, Hui Qin, Zeyan Zhao, Suqi Wang, Wei‐Min He, Shengsong Tang, Junmei Peng

European Journal of Medicinal Chemistry, 279, 116838 · Published 6 September 2024 · DOI 10.1016/j.ejmech.2024.116838

View at the publisherCite this paper

In brief

“Nitrogen-containing heterocyclic drug products approved by the FDA in 2023: Synthesis and biological activity” is a 2024 review article by Weijiang Luo and 7 co-authors, published in European Journal of Medicinal Chemistry. OpenAlex counts 113 citations as of 15 November 2026, which puts it in the top 7% of works published in 2024 by citations. The publisher's version is not open access, and OpenAlex records no free legal copy.

Citations
113
Most cited in
2026 (60)
Field-weighted impact
4.40
References
94
Authors
8

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Luo, W., Liu, Y., Qin, H., Zhao, Z., Wang, S., He, W., Tang, S., & Peng, J. (2024). Nitrogen-containing heterocyclic drug products approved by the FDA in 2023: Synthesis and biological activity. European Journal of Medicinal Chemistry, 279, 116838. https://doi.org/10.1016/j.ejmech.2024.116838

MLA 9

Luo, Weijiang, et al. “Nitrogen-containing heterocyclic drug products approved by the FDA in 2023: Synthesis and biological activity.” European Journal of Medicinal Chemistry, vol. 279, 2024, p. 116838. https://doi.org/10.1016/j.ejmech.2024.116838.

Chicago

Luo, Weijiang, Yiqi Liu, Hui Qin, Zeyan Zhao, Suqi Wang, Wei‐Min He, Shengsong Tang, and Junmei Peng. 2024. “Nitrogen-containing heterocyclic drug products approved by the FDA in 2023: Synthesis and biological activity.” European Journal of Medicinal Chemistry 279: 116838. https://doi.org/10.1016/j.ejmech.2024.116838.

Harvard

Luo, W. et al. (2024) ‘Nitrogen-containing heterocyclic drug products approved by the FDA in 2023: Synthesis and biological activity’, European Journal of Medicinal Chemistry, 279, p. 116838. doi:10.1016/j.ejmech.2024.116838.

IEEE

W. Luo et al., “Nitrogen-containing heterocyclic drug products approved by the FDA in 2023: Synthesis and biological activity,” European Journal of Medicinal Chemistry, vol. 279, p. 116838, 2024, doi: 10.1016/j.ejmech.2024.116838.

BibTeX

@article{luo2024nitrogen,
  title     = {{Nitrogen-containing heterocyclic drug products approved by the FDA in 2023: Synthesis and biological activity}},
  author    = {Luo, Weijiang and Liu, Yiqi and Qin, Hui and Zhao, Zeyan and Wang, Suqi and He, Wei‐Min and Tang, Shengsong and Peng, Junmei},
  journal   = {European Journal of Medicinal Chemistry},
  year      = {2024},
  volume    = {279},
  pages     = {116838},
  doi       = {10.1016/j.ejmech.2024.116838},
  url       = {https://doi.org/10.1016/j.ejmech.2024.116838}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Citations by year

YearCitationsShare of the best year
202422
20255151
20266060

Its field-weighted citation impact is 4.40: it has been cited 4.40 times as often as the average work of the same field, type and year (1.00 is the world average).

Topic and keywords

Physical Sciences › Chemistry › Organic Chemistry › Heterocyclic Compound Synthesis and Bioactivity

  • nitrogen heterocycles
  • FDA-approved drugs
  • drug synthesis
  • biological activity
  • pyrrole
  • imidazole
  • pyrazole derivatives
  • isoxazoles

Work with this paper

Most-cited papers in Chemistry

All highly cited Chemistry papers

Questions about this paper

How do I cite this paper in APA style?

Luo, W., Liu, Y., Qin, H., Zhao, Z., Wang, S., He, W., Tang, S., & Peng, J. (2024). Nitrogen-containing heterocyclic drug products approved by the FDA in 2023: Synthesis and biological activity. European Journal of Medicinal Chemistry, 279, 116838. https://doi.org/10.1016/j.ejmech.2024.116838

How many times has this paper been cited?

113 times, according to OpenAlex on 15 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

OpenAlex records no free legal copy. Check your library's access, the authors' pages or a repository, or ask the corresponding author for a copy.

Who wrote this paper?

Weijiang Luo, Yiqi Liu, Hui Qin, Zeyan Zhao, Suqi Wang, Wei‐Min He, Shengsong Tang, Junmei Peng.

What is the DOI of this paper?

10.1016/j.ejmech.2024.116838. The permanent link is https://doi.org/10.1016/j.ejmech.2024.116838.

Bibliographic data from OpenAlex (CC0), last checked 15 November 2026. ResearchGuru does not host this paper; the links go to the publisher or the repository that does.